S&P 500   3,850.78
DOW   31,169.48
QQQ   323.63
S&P 500   3,850.78
DOW   31,169.48
QQQ   323.63
S&P 500   3,850.78
DOW   31,169.48
QQQ   323.63
S&P 500   3,850.78
DOW   31,169.48
QQQ   323.63
Log in

Alphatec Stock Forecast, Price & News

+0.34 (+2.37 %)
(As of 01/20/2021 01:44 PM ET)
Today's Range
Now: $14.68
50-Day Range
MA: $13.21
52-Week Range
Now: $14.68
Volume8,275 shs
Average Volume776,075 shs
Market Capitalization$1.15 billion
P/E RatioN/A
Dividend YieldN/A
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to meet the surgeon's needs and to maximize patient outcomes; LLICO access system, a minimally invasive posterior thoracolumbar access system; Invictus Spinal Fixation System, a comprehensive thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep designed to improve surgical efficiency without compromising accuracy. It also provides Arsenal spinal fixation system intended for posterior, non-cervical fixation in skeletally mature patients for treating degenerative disc disease, spondylolisthesis, fracture or dislocation, spinal stenosis, curvatures, tumor, pseud arthrosis, and failed previous fusion; zodiac degenerative spinal fixation system, a comprehensive spinal system used to address degenerative spinal conditions and deformity correction; OsseoScrew system to restore the integrity of the spinal column; trestle luxe anterior cervical plate system; and solanas posterior cervico/thoracic fixation system and avalon occipital plate. In addition, the company offers IdentiTi Porous Ti and Transcend Lateral Interbody Implants; Battalion PC; Novel SD; Solus Anterior Lumbar Interbody Fusion System. Further, it is developing EOS imaging products. Additionally, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Alphatec logo


Overall MarketRank

0.83 out of 5 stars

Medical Sector

1100th out of 1,928 stocks

Surgical & Medical Instruments Industry

104th out of 170 stocks

Analyst Opinion: 1.5Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
Current SymbolNASDAQ:ATEC



Sales & Book Value

Annual Sales$113.43 million
Book Value$0.71 per share


Net Income$-57,000,000.00


Market Cap$1.15 billion
Next Earnings Date3/4/2021 (Estimated)
OptionableNot Optionable
+0.34 (+2.37 %)
(As of 01/20/2021 01:44 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ATEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Alphatec (NASDAQ:ATEC) Frequently Asked Questions

How has Alphatec's stock been impacted by Coronavirus?

Alphatec's stock was trading at $4.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ATEC shares have increased by 232.9% and is now trading at $14.68.
View which stocks have been most impacted by COVID-19

Is Alphatec a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Alphatec stock.
View analyst ratings for Alphatec
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Alphatec?

Wall Street analysts have given Alphatec a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Alphatec wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Alphatec's next earnings date?

Alphatec is scheduled to release its next quarterly earnings announcement on Thursday, March 4th 2021.
View our earnings forecast for Alphatec

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) issued its quarterly earnings data on Thursday, November, 5th. The medical technology company reported ($0.24) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.25) by $0.01. The medical technology company earned $41.16 million during the quarter, compared to analysts' expectations of $40.83 million. Alphatec had a negative net margin of 51.95% and a negative return on equity of 266.45%.
View Alphatec's earnings history

What guidance has Alphatec issued on next quarter's earnings?

Alphatec issued an update on its fourth quarter 2020 IntraDay earnings guidance on Tuesday, January, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $43.8-44.1 million, compared to the consensus revenue estimate of $43.66 million.

What price target have analysts set for ATEC?

6 brokers have issued 1-year price targets for Alphatec's shares. Their forecasts range from $9.00 to $20.00. On average, they expect Alphatec's share price to reach $14.33 in the next twelve months. This suggests that the stock has a possible downside of 2.4%.
View analysts' price targets for Alphatec
or view Wall Street analyst' top-rated stocks.

Who are some of Alphatec's key competitors?

What other stocks do shareholders of Alphatec own?

Who are Alphatec's key executives?

Alphatec's management team includes the following people:
  • Mr. Patrick S. Miles, Exec. Chairman, CEO & Pres (Age 55, Pay $1.23M)
  • Mr. Jeffrey G. Black, Exec. VP & CFO (Age 52, Pay $652.76k)
  • Mr. David P. Sponsel, Exec. VP of Sales (Age 42, Pay $768.18k)
  • Mr. Craig E. Hunsaker, Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel (Age 57)
  • Mr. Brian R. Snider, Exec. VP of Marketing & Devel. (Age 43)
  • Mr. Jonathan Allen, Exec. VP of Commercial Operations (Age 61)
  • Dr. Luiz Pimenta, Chief Medical Officer
  • Ms. Kelli Mari Howell, Exec. VP of Clinical Strategies (Age 47)
  • Mr. Mark D. Ojeda, Exec. VP of Cervical & Biologics (Age 51)
  • Mr. Eric Dasso, Exec. VP of Adjunctive Technologies (Age 48)

What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

Who are Alphatec's major shareholders?

Alphatec's stock is owned by a number of institutional and retail investors. Top institutional investors include Columbus Circle Investors (1.09%) and Mesirow Financial Investment Management Inc. (0.07%). Company insiders that own Alphatec stock include Craig E Hunsaker, David Sponsel, Evan Bakst, James L L Tullis, Jeffrey G Black, Jeffrey P Rydin and Kelli Mari Howell.
View institutional ownership trends for Alphatec

Which major investors are selling Alphatec stock?

ATEC stock was sold by a variety of institutional investors in the last quarter, including Mesirow Financial Investment Management Inc.. Company insiders that have sold Alphatec company stock in the last year include Craig E Hunsaker, David Sponsel, James L L Tullis, and Jeffrey G Black.
View insider buying and selling activity for Alphatec
or view top insider-selling stocks.

Which major investors are buying Alphatec stock?

ATEC stock was acquired by a variety of institutional investors in the last quarter, including Columbus Circle Investors. Company insiders that have bought Alphatec stock in the last two years include David Sponsel, Evan Bakst, and Kelli Mari Howell.
View insider buying and selling activity for Alphatec
or or view top insider-buying stocks.

How do I buy shares of Alphatec?

Shares of ATEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $14.68.

How big of a company is Alphatec?

Alphatec has a market capitalization of $1.15 billion and generates $113.43 million in revenue each year. The medical technology company earns $-57,000,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis. Alphatec employs 227 workers across the globe.

What is Alphatec's official website?

The official website for Alphatec is www.atecspine.com.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The medical technology company can be reached via phone at 760-431-9286 or via email at [email protected]

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.